Clinical observation of clarithromycin treatment for nasosinusitis after nasopharyngeal carcinoma radiotherapy.
- Author:
Zunbin KE
1
;
Rongde TANG
;
Jianhua TAN
;
Zhijian JIANG
;
Zhifang LIANG
;
Shaobin FENG
Author Information
1. Department of Otorhinolaryngology, Guangzhou University of Chinese Medicine Affiliated Xinhui hospital of Chinese Medicine, Jiangmen, 529100, China.
- Publication Type:Clinical Trial
- MeSH:
Adult;
Aged;
Carcinoma, Squamous Cell;
diagnostic imaging;
Clarithromycin;
administration & dosage;
therapeutic use;
Female;
Humans;
Male;
Middle Aged;
Nasopharyngeal Neoplasms;
radiotherapy;
Radiography;
Sinusitis;
drug therapy;
etiology;
Treatment Outcome
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2010;24(7):299-303
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the clinical treatment effectiveness of clarithromycin for naso-sinusitis after nasopharyngeal carcinoma radiotherapy.
METHOD:Twenty-four cases of naso-sinusitis after one year nasopharyngeal carcinoma radiotherapy were treated with the oral clarithromycin of small dosage (250 mg everyday). The course of treatment were for 12 to 20 weeks. The treatment effectiveness were evaluated with the chronic naso-sinusitis visual analog quality table mark system (VAS) and Lund-Mackay nasal sinuses CT image mark system before and after treatment.
RESULT:The VAS mark and CT image mark have significant deviation (P < 0.01) among pretherapy, post-treatment and 6 months after drug withdrawal. No significant deviation was found(P > 0.05) between post treatment and 6 months after drug withdrawal. The treatment effectiveness was judged for very good is 9 cases, for the good is 11 cases and for the bad is 4 cases.
CONCLUSION:The clarithromycin of small dosage for long-term treatment of naso-sinusitis after nasopharyngeal carcinoma radiotherapy has positive clinical treatment effectiveness, which is a better treatment method.
